<code id='69F13AA553'></code><style id='69F13AA553'></style>
    • <acronym id='69F13AA553'></acronym>
      <center id='69F13AA553'><center id='69F13AA553'><tfoot id='69F13AA553'></tfoot></center><abbr id='69F13AA553'><dir id='69F13AA553'><tfoot id='69F13AA553'></tfoot><noframes id='69F13AA553'>

    • <optgroup id='69F13AA553'><strike id='69F13AA553'><sup id='69F13AA553'></sup></strike><code id='69F13AA553'></code></optgroup>
        1. <b id='69F13AA553'><label id='69F13AA553'><select id='69F13AA553'><dt id='69F13AA553'><span id='69F13AA553'></span></dt></select></label></b><u id='69F13AA553'></u>
          <i id='69F13AA553'><strike id='69F13AA553'><tt id='69F13AA553'><pre id='69F13AA553'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:75823

          This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

          Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

          advertisement

          The contrarian view of Viking Therapeutics

          Closeup financial chart

          The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          As a primary care physician, here's how I hope to partner with AI
          As a primary care physician, here's how I hope to partner with AI

          AdobeIambothexcitedandterrifiedbytheentranceofartificialintelligenceintomyprimarycarepractice.AI’sen

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Study finds gene variants tied to breast cancer risk in Black women

          AdobeHundredsofgeneticvariantscannudgesomeone’sriskofbreastcancerupordownortowardsaparticularsubtype